Search
forResearch 10 of 44
- Dermatological adverse events with taxane chemotherapy
- Permanent chemotherapy-induced alopecia: Case report and review of the literature
- Irreversible and severe alopecia following docetaxel or paclitaxel cytotoxic therapy for breast cancer
- Cutaneous Reactions to Chemotherapeutic Agents
- Weekly docetaxel in minimally pretreated cancer patients: A dose-escalation study focused on feasibility and cumulative toxicity of long-term administration
- Cutaneous angiosarcoma of the face and scalp presenting as alopecia
- High incidence of severe hand–foot syndrome during capecitabine–docetaxel combination chemotherapy
- Impact of Reporter Type on Signal Detection of Cancer Therapy-Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- Impact of Reporter Type on Signal Detection of Cancer Therapy–Induced Alopecia: A Hypothesis-Generating Study Using the FDA Adverse Event Reporting System
- 203 Inhibin A is downregulated during chemotherapy in patients with breast cancer
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →